R

Redhill Biopharma Ltd
D

RDHL

4.81000
USD
-0.08
(-1.64%)
مغلق
حجم التداول
136
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
6,246,564
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -0.350
    (-0.47%)
    74.220 USD
    B
    BCRX
    -0.17000
    (-1.81%)
    9.20000 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NNVC
    0.05500
    (3.82%)
    1.49500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    V
    VSTM
    0.11500
    (2.06%)
    5.68500 USD
    المزيد
الأخبار
المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.